Msc-and exosome-based immunotherapy

Aharon Brodie; Chaya Brodie

Msc-and exosome-based immunotherapy

Aharon Brodie (Inventor), Chaya Brodie (Inventor)

Research output: Patent

Abstract

Compositions comprising at least one of miR that down regulates PD-L1/PD-1, MSCs expressing same, or exosomes from those MSCs are provided. Methods of decreasing PD-L1 expression, PD-1 expression or both and treating PD-L1 positive cancers using same are also provided.

Original language	English
Patent number	US20210260141A1
State	Published - 26 Aug 2021

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Cite this

@misc{ccc972c932cf46e9bd7cedc178dd540b,

title = "Msc-and exosome-based immunotherapy",

abstract = "Compositions comprising at least one of miR that down regulates PD-L1/PD-1, MSCs expressing same, or exosomes from those MSCs are provided. Methods of decreasing PD-L1 expression, PD-1 expression or both and treating PD-L1 positive cancers using same are also provided.",

author = "Aharon Brodie and Chaya Brodie",

note = "US Patent App. 17/261,078; US20210260141A1",

year = "2021",

month = aug,

day = "26",

language = "الإنجليزيّة",

type = "Patent",

}

TY - PAT

T1 - Msc-and exosome-based immunotherapy

AU - Brodie, Aharon

AU - Brodie, Chaya

N1 - US Patent App. 17/261,078

PY - 2021/8/26

Y1 - 2021/8/26

N2 - Compositions comprising at least one of miR that down regulates PD-L1/PD-1, MSCs expressing same, or exosomes from those MSCs are provided. Methods of decreasing PD-L1 expression, PD-1 expression or both and treating PD-L1 positive cancers using same are also provided.

AB - Compositions comprising at least one of miR that down regulates PD-L1/PD-1, MSCs expressing same, or exosomes from those MSCs are provided. Methods of decreasing PD-L1 expression, PD-1 expression or both and treating PD-L1 positive cancers using same are also provided.

UR - https://patents.google.com/patent/US20210260141A1/en

M3 - براءة الإختراع

M1 - US20210260141A1

ER -

Msc-and exosome-based immunotherapy

Abstract

UN SDGs

Other files and links

Cite this